Medicine and Dentistry
Triple Negative Breast Cancer
100%
Eribulin
100%
Breast Cancer Cell Line
100%
In Vitro
11%
Antiproliferative Activity
11%
Cell Viability Assay
11%
Real-Time Polymerase Chain Reaction
11%
Programmed Cell Death
11%
Malignant Transformation
11%
Apoptosis Assay
11%
Pharmacology, Toxicology and Pharmaceutical Science
Triple Negative Breast Cancer
100%
Eribulin
100%
Cell Viability
22%
Breast Cancer
22%
Malignant Transformation
11%
Viability Assay
11%
Apoptosis Assay
11%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Mesylate
100%
Programmed Cell Death
16%
Real-Time Polymerase Chain Reaction
16%
Apoptosis Assay
16%
Malignant Transformation
16%
Immunology and Microbiology
Breast Cancer Cell Line
100%
Programmed Cell Death
33%
Real-Time Polymerase Chain Reaction
16%